Inventor · disambiguated record
Archana Thakur
Also filed as: THAKUR ARCHANA · THAKUR ARCHANA B
7 granted patents·13 pending applications·22 citations·filing 2013–2025
81Inventor score
Files withABBVIE INC9UNIV PENNSYLVANIA4UNIV VIRGINIA PATENT FOUNDATION4MEDICAL COLLEGE OF WISCONSIN INC3
Top patents by PatentIndex Score
20 records- 0190US11890301B2Methods and compositions for cells expressing a chimeric intracellular signaling moleculeUNIV PENNSYLVANIA·Filed 2016·Granted Feb 6, 2024·4 cites·8 claims
- 0289US9725515B2Prolactin receptor binding proteins and uses thereofABBVIE INC·Filed 2013·Granted Aug 8, 2017·10 cites·50 claims
- 0387US11667721B2CD30 bispecific antibodies and method of immunotherapy of CD30+ malignanciesMEDICAL COLLEGE OF WISCONSIN INC·Filed 2019·Granted Jun 6, 2023·4 cites·17 claims
- 0484US10640563B2Anti-B7-H3 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Granted May 5, 2020·3 cites·3 claims
- 0579US2025346680A1System and method for the development of cd30 bispecific antibodies for immunotherapy of cd30+ malignanciesMEDICAL COLLEGE OF WISCONSIN INC·Filed 2025·Application pending·0 cites
- 0676US12391764B2Anti-CD30 and anti-CD3 bispecific antibodies and methods of immunotherapy for CD30+ malignanciesMEDICAL COLLEGE OF WISCONSIN INC·Filed 2023·Granted Aug 19, 2025·0 cites·34 claims
- 0775US2024342213A1Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling MoleculeUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 0872US10184003B2Prolactin receptor binding proteins and uses thereofABBVIE INC·Filed 2016·Granted Jan 22, 2019·1 cites·30 claims
- 0972US2024026293A1Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling MoleculeUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1065US2021312797A9Prolactin receptor binding proteins and uses thereofABBVIE INC·Filed 2020·Application pending·0 cites
- 1161US2024415890A1Infusion of fresh immune effector cells armed with multispecific antibodyUNIV VIRGINIA PATENT FOUNDATION·Filed 2022·Application pending·0 cites
- 1258US2019153110A1Prolactin receptor binding proteins and uses thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 1357US11649435B2Methods and compositions for cells expressing a chimeric intracellular signaling moleculeUNIV PENNSYLVANIA·Filed 2016·Granted May 16, 2023·0 cites·19 claims
- 1457US2021171637A1Anti-b7-h3 antibodies and antibody drug conjugatesABBVIE INC·Filed 2020·Application pending·0 cites
- 1551US2022273718A1Bispecific antibody targeting of t regulatory cells for treatment of inflammatory conditionsUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 1650US2022175836A1Priming with targeted activated t cells can enhance chemo responsiveness of cancer cellsUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 1749US2023043806A1Induction of highly efficacious anti-tumor and immune modulating activity: cell-free off the shelf therapeutic modalityUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 1843US2020338209A1Anti-b7-h3 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 1943US2014199319A1Methods for increasing the efficiency of hybridoma generationABBVIE INC·Filed 2013·Application pending·0 cites
- 2039US2020002421A1Anti-b7-h3 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Archana Thakur files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →